2.02%| Prev Close: | 2.81 |
|---|---|
| Open: | 2.80 |
| Bid: | 2.65 |
| Ask: | 2.85 |
| 1y Target Est: | 3.33 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 2.78 - 2.84 |
|---|---|
| 52wk Range: | 2.03 - 2.90 |
| Volume: | 178,926 |
| Avg Vol (3m): | 41,644 |
| Market Cap: | 1.60B |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in AUD.
Headlines
- HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be WebcastPR Newswire(Sat 11 May)
- HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012PR Newswire(Tue 30 Apr)
- HeartWare Schedules First Quarter Conference Call And WebcastPR Newswire(Mon 15 Apr)
- HeartWare International, Inc. Announces Closing of Public Offering of Common StockPR Newswire(Tue 19 Mar)
- HeartWare International, Inc. Announces Pricing of Public Offering of Common StockPR Newswire(Wed 13 Mar)
- HeartWare International, Inc. Announces Public Offering of Common StockPR Newswire(Tue 12 Mar)
- HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be WebcastPR Newswire(Thu 7 Mar)
- HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be WebcastPR Newswire(Fri 1 Mar)
- HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 MillionPR Newswire(Wed 27 Feb)
- HeartWare Schedules Fourth Quarter Conference Call and WebcastPR Newswire(Wed 20 Feb)
Press Releases
- HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy TrialPR Newswire(Mon 17 Jun)
- HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be WebcastPR Newswire(Thu 13 Jun)
- HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)PR Newswire(Wed 12 Jun)